Recruiting studies: Factor Xa Inhibitor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
Phase 3 · 64 location(s) · Takeda · NCT05156983 Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)
Phase N/A · 61 location(s) · AstraZeneca · NCT05454787 Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replac
Phase 4 · 16 location(s) · Joon Bum Kim · NCT04258488 Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
Phase 4 · 1 location(s) · Asian Institute Of Medical Sciences · NCT07521332 Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal Dise
Phase 4 · 6 location(s) · Hospital Sirio-Libanes · NCT06402851 VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization
Phase 4 · 1 location(s) · Science Valley Research Institute · NCT06873321 Thrombolysis in Factor Xa-inhibitors Trial
Phase 3 · 13 location(s) · Guri Hagberg · NCT06878066 Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis
Phase 1 · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT04874428

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.